RPRX 241220 25.00P (RPRX241220P25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

RPRX241220P25000

Watchlist

0.35
+0.14+66.67%

15min DelayClose Dec 13 15:59 ET

0.36High0.27Low

Intraday

5D
Daily

News

Here's Why Agios Stock Plummeted More Than 20% on Monday
Zacks Dec 10 10:00 ET
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Seeking AlphaDec 6 16:21 ET
First Solar and 2 More Cheap Stocks to Consider
BarronsDec 5 14:40 ET
Insiders At Royalty Pharma Sold US$42m In Stock, Alluding To Potential Weakness
Simply Wall StDec 5 06:14 ET
How Royalty Pharma, Open Text And VICI Properties Can Put Cash In Your Pocket
Yahoo FinanceNov 29 08:00 ET
Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswireNov 27 16:15 ET

Comments

Trytosaveabit

Nov 4 15:05

News

$Syndax Pharmaceuticals (SNDX.US)$ $Royalty Pharma (RPRX.US)$ Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)
Dow Jones· 1 min ago

Moomoo AI

Feb 22 04:36

Unusual items boosting Royalty Pharma's profit may not recur, possibly causing a profit drop this year. The company's statutory earnings may not truly reflect its underlying earnings power. Investors should note 4 warning signs for Royalty Pharma.

There May Be Underlying Issues With The Quality Of Royalty Pharma's (NASDAQ:RPRX) Earnings

Moomoo AI

Dec 18, 2023 05:24

Significant insider share selling might worry some shareholders despite the implication of the company acting in all shareholders' interest. The overall analysis of insider transactions, however, lacks confidence.

This Insider Has Just Sold Shares In Royalty Pharma

Explore moomoo's "Insider Activity" for institutional sentiment

Alvinnnnnnngenius

Oct 19, 2023 07:01

News watch

$Royalty Pharma (RPRX.US)$

ChapmanJack

Jun 26, 2023 08:50

$Royalty Pharma (RPRX.US)$ ur past dur.. lets pop